Latest SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC Stock Portfolio

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC Performance:

2025 Q4: 13.22%YTD: 43.38%2024: 41.73%

Performance for 2025 Q4 is 13.22%, and YTD is 43.38%, and 2024 is 41.73%.

About SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings

On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC reported an equity portfolio of $4.8 Billions as of 31 Dec, 2025.

The top stock holdings of SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC are , , INSM. The fund has invested 3.6% of it's portfolio in SANDISK CORP and 3.3% of portfolio in GE VERNOVA INC.

The fund managers got completely rid off VERONA PHARMA PLC (VRNA), COMMVAULT SYS INC (CVLT) and MERCADOLIBRE INC (MELI) stocks. They significantly reduced their stock positions in WAYSTAR HLDG CORP, COMFORT SYS USA INC (FIX) and SNOWFLAKE INC (SNOW). SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC opened new stock positions in SITIME CORP (SITM), UPWORK INC (UPWK) and ARTIVION INC (AORT). The fund showed a lot of confidence in some stocks as they added substantially to PALVELLA THERAPEUTICS INC NE, GUARDANT HEALTH INC (GH) and CIDARA THERAPEUTICS INC (CDTX).

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC made a return of 13.22% in the last quarter. In trailing 12 months, it's portfolio return was 43.38%.

Performance
S&P 500

New Buys

Ticker	$ Bought
sitime corp	43,780,700
upwork inc	40,135,500
artivion inc	39,401,000
micron technology inc	37,131,800
five below inc	32,021,200
arrowhead pharmaceuticals in	31,203,300
dycom inds inc	22,639,300
lam research corp	22,595,800

New stocks bought by SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC

Additions

Ticker	% Inc.
palvella therapeutics inc ne	1,015
guardant health inc	674
cidara therapeutics inc	267
natera inc	229
castle biosciences inc	164
credo technology group holdi	96.05
ionis pharmaceuticals inc	95.03
jfrog ltd	77.81

Additions to existing portfolio by SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC

Reductions

Ticker	% Reduced
waystar hldg corp	-82.85
comfort sys usa inc	-50.00
snowflake inc	-43.69
taiwan semiconductor mfg ltd	-42.17
powell inds inc	-40.49
mks inc.	-36.00
analog devices inc	-30.00
viavi solutions inc	-20.94

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
verona pharma plc	-190,521,000
blend labs inc	-4,489,500
adaptive biotechnologies cor	-14,933,800
commvault sys inc	-74,863,200
akero therapeutics inc	-17,907,200
floor & decor hldgs inc	-25,795,000
lenz therapeutics inc	-15,085,300
upstart hldgs inc	-15,240,000

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC got rid off the above stocks

Sector Distribution

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has about 31.1% of it's holdings in Others sector.

Sector	%
Others	31.1
Technology	25
Healthcare	21.6
Industrials	8.2
Consumer Cyclical	5.3
	3.4
Energy	2.7
Real Estate	1.5
Utilities	1.3

Market Cap. Distribution

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has about 44.1% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	36.5
UNALLOCATED	31.3
MID-CAP	17.6
MEGA-CAP	7.6
SMALL-CAP	7

Stocks belong to which Index?

About 43.3% of the stocks held by SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	56.7
RUSSELL 2000	33
S&P 500	10.3

Top 5 Winners (%)		%
	sandisk corp	101.8 %
ESTA	establishment labs hldgs inc	74.3 %
TSEM	tower semiconductor ltd	59.2 %
CDTX	cidara therapeutics inc	56.3 %
BBIO	bridgebio pharma inc	47.0 %

Top 5 Winners ($)		$
	sandisk corp	102.4 M
TSEM	tower semiconductor ltd	45.9 M
CDTX	cidara therapeutics inc	38.0 M
MDB	mongodb inc	31.1 M
INSM	insmed inc	29.3 M

Top 5 Losers (%)		%
VEEV	veeva sys inc	-25.1 %
SPOT	spotify technology s a	-16.6 %
	astera labs inc	-15.0 %
	heartflow inc	-11.5 %
	waystar hldg corp	-8.0 %

Top 5 Losers ($)		$
SPOT	spotify technology s a	-23.5 M
	astera labs inc	-15.0 M
	rubrik inc.	-5.5 M
	heartflow inc	-4.8 M
MSFT	microsoft corp	-4.0 M

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC has 69 stocks in it's portfolio. About 27.8% of the portfolio is in top 10 stocks. SPOT proved to be the most loss making stock for the portfolio. was the most profitable stock for SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC last quarter.

Last Reported on: 17 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
AAON	aaon inc	0.00	0.00	0.00	sold off	-100

ADI	analog devices inc	0.04	7,000	1,898,400	reduced	-30.00

ADPT	adaptive biotechnologies cor	0.00	0.00	0.00	sold off	-100

ADTN	adtran holdings inc	0.00	0.00	0.00	sold off	-100

AEIS	advanced energy inds	1.40	320,918	67,190,600	added	27.96

AGYS	agilysys inc	0.13	54,000	6,417,360	new

AKRO	akero therapeutics inc	0.00	0.00	0.00	sold off	-100

AMZN	amazon com inc	0.21	44,000	10,156,100	new

ANET	arista networks inc	0.00	0.00	0.00	sold off	-100

AORT	artivion inc	0.82	863,867	39,401,000	new

ARGX	argenx se	1.45	82,620	69,479,300	reduced	-10.64

ARWR	arrowhead pharmaceuticals in	0.65	470,000	31,203,300	new

ASND	ascendis pharma a/s	0.00	0.00	0.00	sold off	-100

AXON	axon enterprise inc	0.00	0.00	0.00	sold off	-100

BBIO	bridgebio pharma inc	1.29	813,794	62,247,100	added	0.88

BLND	blend labs inc	0.00	0.00	0.00	sold off	-100

BRZE	braze inc	0.46	651,000	22,322,800	new

CDTX	cidara therapeutics inc	2.19	477,527	105,481,000	added	267

CEG	constellation energy corp	0.96	130,000	45,925,100	unchanged	0.00

CLS	celestica inc	0.02	3,000	886,830	new